Potential Side Effects and Safety Concerns of BPC-157 The safety profile of BPC-157 in humans remains largely unknown due to the absence of properly conducted clinical trials
That said, here's what to know: Common (mild): Injection site redness or irritation
This helps healthcare providers maximize the benefits of B12 injections while reducing risks
On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
Which means dental visits could evolve beyond teeth into early health screening touchpoints
BPC-157 (Body Protection Compound-157) In controlled environments, BPC-157 is studied for its involvement in nitric oxide modulation and tissue integrity